Markets:

Overview

News

Currencies

International

Treasuries

Xenetic Biosciences, Inc. - Common Stock (NQ:XBIO)

2.540 +0.120 (+4.96%)

Streaming Delayed Price Updated: 3:58 PM EST, Dec 4, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Xenetic Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform

November 19, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

November 13, 2025

Via ACCESS Newswire

Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges ↗

October 10, 2025

Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week.

Via Benzinga

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

December 17, 2024

Via ACCESSWIRE

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

October 10, 2025

Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 10, 2025

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

October 10, 2025

Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock

October 10, 2025

Via ACCESS Newswire

4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings ↗

October 09, 2025

Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs....

Via Benzinga

Which stocks are moving before the opening bell on Thursday? ↗

October 09, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

October 09, 2025

Via Benzinga

MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside

October 08, 2025

Via AB Newswire

Topics Artificial Intelligence Intellectual Property

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 08, 2025

Via Benzinga

Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗

October 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 08, 2025

Via Benzinga

Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

October 08, 2025

Via Benzinga

Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results

August 13, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma

July 30, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

July 23, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic

July 08, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 23, 2025

Via Benzinga

Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

May 14, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment

April 09, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma

March 26, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results

March 19, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

March 13, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting

February 27, 2025

Via ACCESS Newswire

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform

December 16, 2024

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.